activina 20 ng Search Results


activin a  (R&D Systems)
98
R&D Systems activin a
Activin A, supplied by R&D Systems, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/activina+20+ng/Recombinant+Human%2FMouse%2FRat+Activin+A+Protein/bio_rxiv__175174-153-21-23
Average 98 stars, based on 1 article reviews
activin a - by Bioz Stars, 2026-10
98/100 stars
  Buy from Supplier
activina  (STEMCELL Technologies Inc)
90
STEMCELL Technologies Inc activina
Schematic of the protocol for the differentiation of cardiomyocytes from human iPSCs and complete EHT experimentation. ( A ) Cardiac differentiation consisted of a first step with 20 ng/mL of BMP4, 20 ng/mL of <t>activinA,</t> and 1.5 µM of CHIR99021 for mesoderm induction, followed by a second step with 5 µM of XAV939 for WNT signal inhibition and cardiac specification, and finally, insulin was added from day 8, after the first beating areas were observed. ( B ) The experimental design started with iPSCs cardio-differentiation and baseline functional measurements before the iPSC-CMs were collected and used for EHT production; later, EHT contractility was measured twice a week for 28 days until the end of the experiment.
Activina, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/activina+20+ng/activin+a/pmc08700676-47-42-43
Average 90 stars, based on 1 article reviews
activina - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
activin a  (Miltenyi Biotec)
94
Miltenyi Biotec activin a
Schematic of the protocol for the differentiation of cardiomyocytes from human iPSCs and complete EHT experimentation. ( A ) Cardiac differentiation consisted of a first step with 20 ng/mL of BMP4, 20 ng/mL of <t>activinA,</t> and 1.5 µM of CHIR99021 for mesoderm induction, followed by a second step with 5 µM of XAV939 for WNT signal inhibition and cardiac specification, and finally, insulin was added from day 8, after the first beating areas were observed. ( B ) The experimental design started with iPSCs cardio-differentiation and baseline functional measurements before the iPSC-CMs were collected and used for EHT production; later, EHT contractility was measured twice a week for 28 days until the end of the experiment.
Activin A, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/activina+20+ng/Human+Activin+A%2C+premium+grade/bio_rxiv__2025__08__25__672056-125-6-9
Average 94 stars, based on 1 article reviews
activin a - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
recombinant human activin a  (R&D Systems)
94
R&D Systems recombinant human activin a
Schematic of the protocol for the differentiation of cardiomyocytes from human iPSCs and complete EHT experimentation. ( A ) Cardiac differentiation consisted of a first step with 20 ng/mL of BMP4, 20 ng/mL of <t>activinA,</t> and 1.5 µM of CHIR99021 for mesoderm induction, followed by a second step with 5 µM of XAV939 for WNT signal inhibition and cardiac specification, and finally, insulin was added from day 8, after the first beating areas were observed. ( B ) The experimental design started with iPSCs cardio-differentiation and baseline functional measurements before the iPSC-CMs were collected and used for EHT production; later, EHT contractility was measured twice a week for 28 days until the end of the experiment.
Recombinant Human Activin A, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/activina+20+ng/Recombinant+Human+Activin+AB+Protein/10__2508_slash_chikusan__81__353-43-22-25
Average 94 stars, based on 1 article reviews
recombinant human activin a - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
human activin a  (R&D Systems)
93
R&D Systems human activin a
Schematic of the protocol for the differentiation of cardiomyocytes from human iPSCs and complete EHT experimentation. ( A ) Cardiac differentiation consisted of a first step with 20 ng/mL of BMP4, 20 ng/mL of <t>activinA,</t> and 1.5 µM of CHIR99021 for mesoderm induction, followed by a second step with 5 µM of XAV939 for WNT signal inhibition and cardiac specification, and finally, insulin was added from day 8, after the first beating areas were observed. ( B ) The experimental design started with iPSCs cardio-differentiation and baseline functional measurements before the iPSC-CMs were collected and used for EHT production; later, EHT contractility was measured twice a week for 28 days until the end of the experiment.
Human Activin A, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/activina+20+ng/Human+Activin+A+DuoSet+ELISA/pmc04943650-58-10-15
Average 93 stars, based on 1 article reviews
human activin a - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
activin a  (HumanZyme)
90
HumanZyme activin a
Schematic of the protocol for the differentiation of cardiomyocytes from human iPSCs and complete EHT experimentation. ( A ) Cardiac differentiation consisted of a first step with 20 ng/mL of BMP4, 20 ng/mL of <t>activinA,</t> and 1.5 µM of CHIR99021 for mesoderm induction, followed by a second step with 5 µM of XAV939 for WNT signal inhibition and cardiac specification, and finally, insulin was added from day 8, after the first beating areas were observed. ( B ) The experimental design started with iPSCs cardio-differentiation and baseline functional measurements before the iPSC-CMs were collected and used for EHT production; later, EHT contractility was measured twice a week for 28 days until the end of the experiment.
Activin A, supplied by HumanZyme, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/activina+20+ng/activin+a/pm20128659-42-13-15
Average 90 stars, based on 1 article reviews
activin a - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
activin a  (MedChemExpress)
95
MedChemExpress activin a
Schematic of the protocol for the differentiation of cardiomyocytes from human iPSCs and complete EHT experimentation. ( A ) Cardiac differentiation consisted of a first step with 20 ng/mL of BMP4, 20 ng/mL of <t>activinA,</t> and 1.5 µM of CHIR99021 for mesoderm induction, followed by a second step with 5 µM of XAV939 for WNT signal inhibition and cardiac specification, and finally, insulin was added from day 8, after the first beating areas were observed. ( B ) The experimental design started with iPSCs cardio-differentiation and baseline functional measurements before the iPSC-CMs were collected and used for EHT production; later, EHT contractility was measured twice a week for 28 days until the end of the experiment.
Activin A, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/activina+20+ng/Activin+A%2C+Human%2FMouse%2FRat/pmc12116958-34-7-9
Average 95 stars, based on 1 article reviews
activin a - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

Image Search Results


Schematic of the protocol for the differentiation of cardiomyocytes from human iPSCs and complete EHT experimentation. ( A ) Cardiac differentiation consisted of a first step with 20 ng/mL of BMP4, 20 ng/mL of activinA, and 1.5 µM of CHIR99021 for mesoderm induction, followed by a second step with 5 µM of XAV939 for WNT signal inhibition and cardiac specification, and finally, insulin was added from day 8, after the first beating areas were observed. ( B ) The experimental design started with iPSCs cardio-differentiation and baseline functional measurements before the iPSC-CMs were collected and used for EHT production; later, EHT contractility was measured twice a week for 28 days until the end of the experiment.

Journal: Cells

Article Title: Development of a 3-Dimensional Model to Study Right Heart Dysfunction in Pulmonary Arterial Hypertension: First Observations

doi: 10.3390/cells10123595

Figure Lengend Snippet: Schematic of the protocol for the differentiation of cardiomyocytes from human iPSCs and complete EHT experimentation. ( A ) Cardiac differentiation consisted of a first step with 20 ng/mL of BMP4, 20 ng/mL of activinA, and 1.5 µM of CHIR99021 for mesoderm induction, followed by a second step with 5 µM of XAV939 for WNT signal inhibition and cardiac specification, and finally, insulin was added from day 8, after the first beating areas were observed. ( B ) The experimental design started with iPSCs cardio-differentiation and baseline functional measurements before the iPSC-CMs were collected and used for EHT production; later, EHT contractility was measured twice a week for 28 days until the end of the experiment.

Article Snippet: In short, a confluent monolayer of human iPSCs was differentiated by adding RPMI media (Thermofisher Scientific) supplemented with B27 minus insulin (Thermofisher Scientific), 50 μg/mL of ascorbic acid (Thermofisher Scientific), 20 ng/mL of BMP4 (R&D Systems, Minneapolis, MN, USA), 20 ng/mL of activinA (StemCell Technologies), and 1.5 μM of CHIR99021 (TOCRIS, Bristol, UK) for 3 days.

Techniques: Inhibition, Functional Assay